Product Information
METFORMIN HCL 625 MG TABLET is a generic product labeled by Lifsa Drugs LLC, priced at $12.5266 per EA under NDC 72336006430. Its NADAC has been published 49 times since Jul 23, 2025.
The High Outlier badge above means this manufacturer's average price in the Metformin Hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
625 mg/1
Manufacturer
Lifsa Drugs LLCNDC
72336006430
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
1/21/2026
Active Ingredients
METFORMIN HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA075972On Market Since
1/24/2002
Pharmacological Classes
Price Statistics
The NADAC for METFORMIN HCL 625 MG TABLET has been published 49 times since Jul 23, 2025, and over the history we have for it it has declined 7.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $12.5266 per EA |
|---|---|
| All-time high | $13.4865 (Aug 13, 2025) |
| All-time low | $12.5158 (Nov 19, 2025) |
| 52-week high | $13.4865 |
| 52-week low | $12.5158 |
| Median price | $12.5266 |
| Average price | $12.6943 |
| Largest weekly change | -2.8% (Aug 20, 2025) |
| Weeks tracked | 49 |
| Tracking since | Jul 23, 2025 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of METFORMIN HCL 625 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for METFORMIN HCL 625 MG TABLET, manufactured by Lifsa Drugs LLC, is $12.5266 per EA (NDC 72336006430), effective Jun 24, 2026.
How has the price of METFORMIN HCL 625 MG TABLET changed over time?
Over the history we have for it, the NADAC for METFORMIN HCL 625 MG TABLET has declined 7.1%. It has been tracked across 49 weekly CMS publications since Jul 23, 2025.
What are the highest and lowest recorded NADAC prices for METFORMIN HCL 625 MG TABLET?
Since Jul 23, 2025, the NADAC for METFORMIN HCL 625 MG TABLET has ranged from a low of $12.5158 (Nov 19, 2025) to a high of $13.4865 (Aug 13, 2025), with a median of $12.5266 per EA.
Are there cheaper alternatives to METFORMIN HCL 625 MG TABLET?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as METFORMIN HCL 625 MG TABLET, but none are currently priced below it.
Who manufactures METFORMIN HCL 625 MG TABLET?
METFORMIN HCL 625 MG TABLET (NDC 72336006430) is labeled by Lifsa Drugs LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification